Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation
01 Pubblicazione su rivista
Pecoraro Y., Carillo C., Diso D., Mantovani S., Cimino G., De Giacomo T., Troiani P., Shafii M., Gherzi Lorenzo, Amore D., Rendina E. A., Venuta F., Anile M.
ISSN: 0041-1345
Lung transplantation (LT) is only therapeutic option for patients affected by chronic respiratory failure. Chronic rejection, also known as bronchiolitis obliterans syndrome (BOS), is still the main cause of death and the most important factor that influences post-transplantation quality of life. Currently available therapies have not been proven to result in significant benefit in the prevention or treatment of BOS. Extracorporeal photopheresis (ECP) seems to reduce the rate of lung function decline in transplant recipients with progressive BOS.